Search results
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 2 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 4 days agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 9 hours agoOn Monday, as part of the annual American Society of Clinical Oncology conference in Chicago, Merck...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 4 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 2 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 2 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Moderna’s stock climbs on report that bird-flu vaccine funding is near
Market Watch· 5 days agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a...
Moderna's RSV vaccine for older adults approved
Axios· 4 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 4 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
